Affinity Selection-Mass Spectrometry (HT-ASMS)

Axcelead Navigator introduces our revolutionary High Throughput-Affinity Selection Mass Spectrometry(HT-ASMS).
HT-ASMS is a technique for identifying hit compounds based on biological activity using binding to the target molecules as an indicator. It enables the discovery of small molecules that bind specifically to target DNA, RNA and targeted protein degradation.

Axcelead has now developed an online LC/TOF-MS system dedicated to HT-ASMS, which combines size-exclusion chromatography and reversed-phase chromatography. With this system, we swiftly identify hit compounds from our proprietary library.

Backed by a highly experienced team, we have a proven track record in high-throughput screening and are committed to meeting your unique requirements in drug discovery.

Curious to learn more? www.axcelead.com/en/service/10294/

Contact us now to explore the possibilities!

【About Axcelead】
www.axcelead.com/en/
Axcelead is the first integrated drug discovery solutions provider in the pharmaceutical industry in Japan, having inherited the unique and comprehensive capabilities of drug discovery from Takeda Pharmaceutical Company Limited： “Experienced Scientists”, “Cutting-edge Technology Platform”, and “Huge Historical Drug Discovery Data”, and started its business in 2017.

・Subscribe Axcelead Newsletter
go.axcelead.com/l/996261/2023-01-11/8kjv
・Linkedin
www.linkedin.com/company/axcelead-drug-discovery-p…